Atlas Trials

Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC

Clinical trial NCT07250360 · COMPLETED

Trial details

NCT number
NCT07250360
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
COMPLETED
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer Stage I
Start date
2015-01-01
Primary completion
2019-12-31
Enrollment
2072

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.